ARCHIVES

Phase III Nexavar Trial Fails Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

Elderly Men Say Physicians Are Recommending PSA Tests

December 26, 2003

National Health Organizations Warn of Risks in Indoor Tanning

April 29, 2011

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

May 27, 2005

HHS Group To Study Policies Affecting Academic Centers

June 20, 1997

Congressional Report Days NCI Ignored Data, Procedure, In Changes To Screening Guidelines

November 4, 1994

Robert Day Advocates NCI Payment for Investigator Salaries

May 7, 1999